Diagnosis of Parkinson Disease

Making an accurate diagnosis of Parkinson’s particularly in its early stages — is difficult. The use of functional neuroimaging in neurodegenerative diseases has increased in recent years, with applications in research in the underlying pathophysiology, aiding in diagnosis, or evaluating new treatments. In Parkinson's disease (PD), these imaging ways have expanded our understanding of the disease on the far side dopaminergic deficits area unit of diagnostics and Neuroimaging for Parkinson disease are Clinical pathological and genetic overlap in parkinsonism, Detecting prodromal Parkinson’s disease, Nuclear imaging to study Laboratory investigations supporting the diagnosis of MSA, PSP and CBD, Utility of next generation sequencing in the diagnosis of parkinsonian disorders, Clinic-genetic correlations in parkinsonian disorders, Therapeutic strategies in genetic forms of proteinopathies,  pathophysiology to new treatment strategies Insights from the laboratory and Disease-modifying, animal models and Symptomatic treatments, Update on surgical and medical treatment of the dystonia’s, Instrumental analysis of tremor, Instrumental analysis of parkinsonian symptoms, analysis of gait and postural reflexes, Neuroprotective treatments and Complementary Therapy.

Accurate diagnosis of Parkinson Disease, and other forms of parkinsonism, and ET can be a challenge. The most common differential diagnoses include essential tremor (ET); atypical parkinsonism such as progressive supranuclear palsy (PSP), multiple system atrophy (MSA), diffuse Lewy body (DLB) disease, and corticobasal degeneration (CBD); Alzheimer disease; and vascular, drug-induced, and psychogenic parkinsonism. In a study of 100 patients clinically diagnosed with Parkinson Disease by a general neurologist, autopsy findings revealed a diagnostic accuracy of 76%. In another study of patients diagnosed with parkinsonism in the community, 15% were misdiagnosed with PD and 19% had PD but were diagnosed with another disorder. The majority of those misdiagnoses were ET. The autopsy is the only way to definitively diagnose PD The correct diagnosis depends largely on the expertise of the physician and a good clinical history. In difficult cases, neuroimaging may serve as a tool to improve diagnostic accuracy, particularly between PD and ET.

  • Instrumental analysis of tremor
  • Instrumental analysis of parkinsonian symptoms
  • Complementary Therapy
  • Neuroprotective treatments
  • Analysis of gait and postural reflexes
  • Detecting prodromal Parkinsons disease
  • Clinical pathological and genetic overlap in parkinsonism
  • Nuclear imaging to study parkinsonian disorders
  • Disease modifying and symptomatic treatments
  • Myoclonus, Etiology, pathophysiology and treatment
  • Clinico-genetic correlations in parkinsonian disorders
  • Therapetuic strategies in genetic forms of proteinopathies
  • Update on medical and surgical treatment of the dystonias
  • Laboratory investigations supporting the diagnosis of MSA and PSP/CBD
  • Utility of next generation sequencing in the diagnosis of parkinsonian disorders
  • Pathophysiology to new treatment strategies: Insights from the laboratory and animal models
  • Huntington’s disease: From natural history studies to experimental therapeutics

Related Conference of Diagnosis of Parkinson Disease

August 29-31, 2017

15th European Neurology Congress

London, UK
August 29-31, 2017

6th World Congress on Addiction Disorder & Addiction Therapy

Prague, Czech Republic
August 31-September 01, 2017

3rdInternational Conference on Epilepsy and Treatment

Brussels, Belgium
September 07-08, 2017

Global Experts Meeting on Brain Disorders

Macau, Hong Kong
November 16-17, 2017

Global Experts Meeting on Neurological Disorders and Stroke

Melbourne, Australia
Oct 12-13, 2017

Internatinal Meeting on Addiction Congress

Osaka, Japan
Oct 12-13, 2017

Global Meeting on Dual Diagnosis and Addiction

Auckland, Newzeland
October 16-17, 2017

17th Global Neuroscience Conference

Osaka, Japan
Nov 13-14, 2017

Gobal Experts Meeting on Neuroscience and Neurochemistry

Melbourne, Australia
February 22-23, 2018

10th International Conference on Vascular Dementia

Paris, France
July 16-17, 2018

25th World Congress on Neurology and Neurodisorders

Melbourne, Australia
September 17-18, 2018

International Conference on Nervous System and Nerve Diseases

Philadelphia , USA
August 29-30, 2018

4th World Congress on Parkinsons and Huntington Disease

Zurich, Switzerland
September 10-12, 2018

4th International Conference on Spine and Spinal Disorders

Dublin, Ireland

Diagnosis of Parkinson Disease Conference Speakers

Recommended Sessions

Related Journals

Are you interested in